Steve Brozak

Stock Analyst at WBB Securities

(0.48)
# 4,038
Out of 4,918 analysts
8
Total ratings
30%
Success rate
-12.37%
Average return

Stocks Rated by Steve Brozak

Cidara Therapeutics
Jun 23, 2025
Reiterates: Strong Buy
Price Target: $45
Current: $62.90
Upside: -28.46%
Marker Therapeutics
Apr 1, 2025
Reiterates: Strong Buy
Price Target: $13
Current: $1.35
Upside: +825.93%
Omeros
Jun 18, 2021
Maintains: Strong Buy
Price Target: $75$100
Current: $3.61
Upside: +2,670.08%
RedHill Biopharma
May 28, 2021
Downgrades: Buy
Price Target: $17,000$16,000
Current: $1.20
Upside: +1,333,233.33%